The ROE as of November 2024 (TTM) for Unity Biotechnology, Inc. (UBX) is -101.47%

According to Unity Biotechnology, Inc.’s latest financial reports and current stock price. The company's current ROE is -101.47%. This represents a change of 262.53% compared to the average of -27.99% of the last 4 quarters.

Unity Biotechnology, Inc. (UBX) Historical ROE (quarterly & annually)

How has UBX ROE performed in the past?

The mean historical ROE of Unity Biotechnology, Inc. over the last ten years is -65.49%. The current -101.47% ROE has changed 54.95% with respect to the historical average. Over the past ten years (40 quarters), UBX's ROE was at its highest in in the March 2018 quarter at 16.36%. The ROE was at its lowest in in the September 2024 quarter at -45.82%.

Unity Biotechnology, Inc. (UBX) ROE by Quarter and Year

Discovering the peaks and valleys of Unity Biotechnology, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Unity Biotechnology, Inc. (UBX) Average ROE

How has UBX ROE performed in the past?

The current ROE of Unity Biotechnology, Inc. (UBX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Unity Biotechnology, Inc. (UBX) ROE vs. Peers

How is UBX’s ROE compared to its peers?

Unity Biotechnology, Inc.’s ROE is greater than Exscientia plc (-52.50%), greater than Recursion Pharmaceuticals, Inc. (-76.53%), greater than Atea Pharmaceuticals, Inc. (-34.90%), greater than Icosavax, Inc. (-20.22%), greater than HOOKIPA Pharma Inc. (-49.25%), greater than Acumen Pharmaceuticals, Inc. (-32.99%), less than Heron Therapeutics, Inc. (76.79%), greater than Homology Medicines, Inc. (-100.91%), greater than Avidity Biosciences, Inc. (-27.66%), greater than Beam Therapeutics Inc. (-16.22%), greater than Intellia Therapeutics, Inc. (-51.97%), greater than Editas Medicine, Inc. (-80.13%), greater than Verve Therapeutics, Inc. (-35.23%), greater than Prime Medicine, Inc. (-114.95%), greater than Windtree Therapeutics, Inc. (-123.93%), greater than Dermata Therapeutics, Inc. (-247.40%), greater than Ensysce Biosciences, Inc. (-268.39%), less than Panbela Therapeutics, Inc. (304.71%), less than Baudax Bio, Inc. (89.01%), greater than Neoleukin Therapeutics, Inc. (-8.54%), greater than Nuvation Bio Inc. (-108.68%), greater than Ovid Therapeutics Inc. (-39.24%), greater than NextCure, Inc. (-62.50%), less than Connect Biopharma Holdings Limited (7.21%),

Build a custom stock screener for Unity Biotechnology, Inc. (UBX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Unity Biotechnology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Unity Biotechnology, Inc. (UBX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Unity Biotechnology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.